Stay updated on Pembrolizumab in NSCLC with PS 2 Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NSCLC with PS 2 Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T01:15:17.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed descriptions of a clinical trial for pembrolizumab in patients with Non-Small Cell Lung Cancer, while retaining key identifiers and collaborators associated with the study.
    Difference
    20%
    Check dated 2025-04-16T14:09:43.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 10, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.
    Difference
    0.5%
    Check dated 2025-04-09T08:48:55.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:06:02.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T21:11:03.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The webpage has been updated to include new results and timelines for the clinical trials involving pembrolizumab, specifically focusing on patients with performance status 2. Key updates include the addition of new reporting dates and a commitment to data sharing for research purposes.
    Difference
    18%
    Check dated 2025-02-17T16:44:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NSCLC with PS 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.